- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06306144
Early-phase Telecare Programs for Minor Stroke (COGaDOM)
Mild Cognitive Impairment After Minor Stroke: Evaluation of Early-phase Telecare Programs (Psychoeducation and Computerized Cognitive Stimulation)
Minor strokes (few acute neurological symptoms ; NIHSS score <5), represent almost 65% of cerebrovascular ischemic events. The increasing incidence of stroke in people under 65, together with advances in diagnostic and revascularization techniques, mean that post-stroke life expectancy is now in the order of decades. Most patients with minor stroke are rapidly discharged from hospital, with follow-up focused on secondary prevention and they are offered little or no rehabilitation.
However, up to 70% of patients with minor stroke experience difficulties resuming their social or professional activities, which can lead to social and economic disruption (delayed/compromised return to work) and an increased risk of depression. While some care recommendations exist for this population, in France there is no consensus nor identified care pathway for follow-up assessment or management of these patients. Furthermore, existing services are unevenly distributed across the country, and research into the effectiveness of rehabilitation is still scarce, leading to uncertainty as to which interventions should be prioritized to decrease difficulties related to cognitive impairment.
Since there are currently no rehabilitation proposals in France for patients with mild cognitive impairment after mild stroke, in this trial the investigaror will investigate the effectiveness of two six-week telerehabilitation programs each consisting of a weekly session supervised by a therapist and a self-rehabilitation session. The aim of this multicenter randomized controlled trial is the evaluate the relevance and feasibility of early identification of patients eligible for a cognition-focused management proposal and the efficacy of two telecare programs, (a) psychoeducation and (b) computerized cognitive rehabilitation.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: PUGNIET Virginie
- Phone Number: 04.78.86.50.64
- Email: virginie.pugniet@chu-lyon.fr
Study Contact Backup
- Name: CHARLOIS Anne-Laure
- Phone Number: 04.78.86.50.64
- Email: anne-laure.charlois@chu-lyon.fr
Study Locations
-
-
-
Bordeaux, France, 33000
- CHU de Bordeaux
-
Contact:
- GLIZE Bertrand
- Phone Number: 05 56 79 56 79
- Email: bertrand.glize@chu-bordeaux.fr
-
Lille, France, 59037
- Chu Lille
-
Contact:
- ALLART Etienne, Dr
- Phone Number: 03 20 44 48 71
- Email: etienne.allart@chu-lille.fr
-
Saint-Genis-Laval, France, 69230
- Hôpital Henry Gabrielle
-
Contact:
- PUGNIET Virginie
- Phone Number: 04.78.86.50.64
- Email: virginie.pugniet@chu-lyon.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Man or woman, aged between 18 and 65 years old
- Hospitalization for a first stroke
- Minor stroke: NIHSS score < 5 on discharge from neurovascular unit
- Post-stroke delay < 8 weeks
- Living at home (not institutionalized)
- Affiliated with social security or benefiting from such a scheme
- French language
- Presence of a cognitive complaint (FACT-Cog "perceived cognitive impairments" subscale score < 55) and absence of major cognitive impairment
- Signature of informed consent
Exclusion Criteria:
- History of stroke
- Uncorrected hearing or visual impairment
- Neurological pathology other than stroke or disabling psychiatric disorder
- Unstabilized epilepsy
- Undergoing cognitive rehabilitation in another context or having integrated a post-stroke therapeutic education program
- Living in a white zone that does not allow for remote rehabilitation
- Unable to connect to the Internet
- Pregnant, parturient or breast-feeding women* (interview data)
- Persons deprived of their liberty by judicial or administrative decision
- Persons admitted to a health or social institution for purposes other than research
- Adults under legal protection (guardianship, curatorship)
- Taking part in other interventional research involving a period of exclusion still in progress at pre-inclusion
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patients receiving the Psychoeducation Intervention
Patients will participate in a 6-week psychoeducation telerehabilitation intervention, that will consist of two 45-minute sessions per week.
Each week they will participate in a 45-minute on-line session with a rehabilitation clinician and later in the week will complete 45 minutes of exercises set by the rehabilitation clinician
|
Arm 1 : Psychoeducation aims to inform patients about post-stroke cognitive impairment, teach them coping strategies to compensate for these difficulties, provide information on symptom recognition and management, and offer emotional and psychological support to help them meet the challenges associated with these potential cognitive impairments.
|
|
Experimental: Patients receiving the Computerised Cognitive Stimulation Intervention
Patients will participate in a 6-week cognitive stimulation telerehabilitation intervention, that will consist of two 45-minute sessions per week.
Each week they will participate in a 45-minute on-line session with a rehabilitation clinician and later in the week will complete 45 minutes of on-line exercises set by the rehabilitation clinician.
|
Arm 2 :Patients will participate in a 6-week cognitive stimulation telerehabilitation intervention, that will consist of two 45-minute sessions per week.
Each week they will participate in a 45-minute on-line session with a rehabilitation clinician and later in the week will complete 45 minutes of on-line exercises set by the rehabilitation clinician
|
|
Experimental: Patients receiving the Usual Care
Patients randomized to this group will complete the questionnaires and the cognitive tests but will receive no intervention
|
Arm 3 : No specific care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The primary objective of this study is to demonstrate the benefits of early management following a minor stroke on participation at 6 months post-stroke.
Time Frame: At the end of the study : 36 months
|
Difference in the Participation score (from the Participation subscale of the stroke impact scale) between the pre-intervention evaluation and the evaluation 6 months post-stroke, between the intervention and non-intervention groups
|
At the end of the study : 36 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
to evaluate the effects on quality of life of the proposed programs at post-intervention, 6 months post-stroke and 9 months post-stroke in comparison with measurements taken before the start of management (pre-intervention visit 1)
Time Frame: At the end of the study : 36 months
|
the effects of the proposed programs will be evaluated with quality of life measured using the WHOQOL-BREF Difference in each outcome measure score between the pre-intervention evaluation and the evaluations post-intervention and at 9 months post-stroke, between the intervention and non-intervention groups.
|
At the end of the study : 36 months
|
|
to evaluate the effects on cognitive complaint of the proposed programs at post-intervention, 6 months post-stroke and 9 months post-stroke in comparison with measurements taken before the start of management (pre-intervention visit 1)
Time Frame: At the end of the study : 36 months
|
the effects of the proposed programs will be evaluated with cognitive complaint measured using the FACT-Cog; Difference in each outcome measure score between the pre-intervention evaluation and the evaluations post-intervention and at 9 months post-stroke, between the intervention and non-intervention groups. |
At the end of the study : 36 months
|
|
to evaluate the effects on cognitive function of the proposed programs at post-intervention, 6 months post-stroke and 9 months post-stroke in comparison with measurements taken before the start of management (pre-intervention visit 1)
Time Frame: At the end of the study : 36 months
|
the effects of the proposed programs will be evaluated with cognitive function (notably attentional, executive and memory functions) measured using a custom-designed battery of neuropsychological tests; Difference in each outcome measure score between the pre-intervention evaluation and the evaluations post-intervention and at 9 months post-stroke, between the intervention and non-intervention groups. |
At the end of the study : 36 months
|
|
to evaluate the effects on mood and anxiety of the proposed programs at post-intervention, 6 months post-stroke and 9 months post-stroke in comparison with measurements taken before the start of management (pre-intervention visit 1)
Time Frame: At the end of the study : 36 months
|
the effects of the proposed programs on mood and anxiety will be measured by the HADS Difference in each outcome measure score between the pre-intervention evaluation and the evaluations post-intervention and at 9 months post-stroke, between the intervention and non-intervention groups. |
At the end of the study : 36 months
|
|
to evaluate the effects on fatigue of the proposed programs at post-intervention, 6 months post-stroke and 9 months post-stroke in comparison with measurements taken before the start of management (pre-intervention visit 1)
Time Frame: At the end of the study : 36 months
|
the effects of the proposed programs on fatigue will be measured by the FACIT-Fatigue Difference in each outcome measure score between the pre-intervention evaluation and the evaluations post-intervention and at 9 months post-stroke, between the intervention and non-intervention groups. |
At the end of the study : 36 months
|
|
to evaluate the effects on participation of the proposed programs at post-intervention, 6 months post-stroke and 9 months post-stroke in comparison with measurements taken before the start of management (pre-intervention visit 1)
Time Frame: At the end of the study : 36 months
|
the effects of the proposed programs on participation will be measured by the score on the Participation subscale of the Stroke Impact Scale Difference in each outcome measure score between the pre-intervention evaluation and the evaluations post-intervention and at 9 months post-stroke, between the intervention and non-intervention groups. |
At the end of the study : 36 months
|
|
to evaluate the effects on health status of the proposed programs at post-intervention, 6 months post-stroke and 9 months post-stroke in comparison with measurements taken before the start of management (pre-intervention visit 1)
Time Frame: At the end of the study : 36 months
|
the effects of the proposed programs on health status will be measured by EQ-5D-5L; Difference in each outcome measure score between the pre-intervention evaluation and the evaluations post-intervention and at 9 months post-stroke, between the intervention and non-intervention groups. |
At the end of the study : 36 months
|
|
to evaluate the effects on health status of the proposed programs at post-intervention, 6 months post-stroke and 9 months post-stroke in comparison with measurements taken before the start of management (pre-intervention visit 1)
Time Frame: At the end of the study : 36 months
|
the effects of the proposed programs on the medico-economic impact of these interventions. Difference in each outcome measure score between the pre-intervention evaluation and the evaluations post-intervention and at 9 months post-stroke, between the intervention and non-intervention groups. |
At the end of the study : 36 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL23_0691
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Minor Stroke
-
First Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruitingMinor Ischemic StrokeChina
-
Peking Union Medical College HospitalNot yet recruitingIschemic Stroke | Minor Stroke
-
The First Affiliated Hospital of Zhengzhou UniversityGeneral Hospital of Shenyang Military Region; Beijing Tiantan Hospital; Shanghai...Completed
-
Rush University Medical CenterActive, not recruitingMinor Surgical Procedures With Monitored Anesthesia Care | Driving Performance After Minor Ambulatory SurgeryUnited States
-
Beijing Tiantan HospitalRecruitingMinor Ischemic StrokeChina
-
University Hospital, Strasbourg, FranceCompletedSurgical Intervention | MinorFrance
-
Chiayi Christian HospitalCompletedChildren Who Underwent Minor Surgery
-
Herlev HospitalRecruitingTransient Ischemic Attack | Non-disabling Stroke | Minor StrokeDenmark
-
Tampere University HospitalTampere University; UKK Institute; University of JyvaskylaUnknown
Clinical Trials on Psychoeducation
-
University of GaziantepCompletedPsychoeducation StudyTurkey (Türkiye)
-
The University of Texas Health Science Center,...TerminatedBipolar Disorder Family MembersUnited States
-
The Hong Kong Polytechnic UniversityHealth and Medical Research FundNot yet recruitingCaregiving Stress
-
IRCCS Centro San Giovanni di Dio FatebenefratelliAlzheimer's Association; University of BergamoCompleted
-
ŞİRİN HARKİNEnrolling by invitationSchizophrenia | Well-being | Caregiver | Psychoeducation | Communication SkillsTurkey
-
University of Alabama at BirminghamCompletedChronic Low Back PainUnited States
-
Virginia Polytechnic Institute and State UniversityUniversity of Virginia; Autism Speaks; National Center for Advancing Translational...CompletedAutism Spectrum DisorderUnited States
-
Istanbul Medeniyet UniversityCompletedElderly People | Depressive Symptoms | DespondencyTurkey
-
University of Missouri, Kansas CityUniversity of KansasCompletedMultiple SclerosisUnited States
-
Uppsala UniversityCompleted